Abstract
In the healthy lung, macrophages maintain homeostasis by clearing inhaled particles, bacteria, and removing apoptotic cells from the local pulmonary environment. However, in respiratory diseases including chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, macrophages appear to be dysfunctional and may contribute to disease pathogenesis. In COPD, phagocytosis of bacterial species and apoptotic cells by both alveolar macrophages and monocyte-derived macrophages is significantly reduced, leading to colonization of the lung with pathogenic bacteria. COPD macrophages also release high levels of pro-inflammatory cytokines and chemokines, including CXCL8, TGFβ, and CCL2, driving recruitment of other inflammatory cells including neutrophils and monocytes to the lungs and promoting disease progression.
In asthma, defective phagocytosis and efferocytosis have also been reported, and macrophages appear to have altered cell surface receptor expression; however, it is as yet unclear how this contributes to disease progression but may be important in driving Th2-mediated inflammation. In cystic fibrosis, macrophages also display defective phagocytosis, and reduced bacterial killing, which may be driven by the pro-inflammatory environment present in the lungs of these patients.
The mechanisms behind defective macrophage function in lung diseases are not currently understood, but potential mechanisms include alterations in phagocytic receptor expression levels, oxidative stress, but also the possibility that specific diseases are associated with a specific, altered, macrophage phenotype that displays reduced function. Identification of the mechanisms responsible may present novel therapeutic opportunities for treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adcock IM, Ford PA, Bhavsar P, Ahmad T, Chung KF (2008) Steroid resistance in asthma: mechanisms and treatment options. Curr Allergy Asthma Rep 8(2):171–178
Alexis NE, Soukup J, Nierkens S, Becker S (2001) Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma. Am J Physiol Lung Cell Mol Physiol 280:369–375
Alexis NE, Muhlebach MS, Peden DB, Noah TL (2006) Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients. J Cyst Fibros 5(1):17–25
Barnawi J, Tran H, Jersmann H, Pitson S, Roscioli E, Hodge G, Meech R, Haberberger R, Hodge S (2015) Potential link between the sphingosine-1-phosphate (S1P) system and defective alveolar macrophage phagocytic function in chronic obstructive pulmonary disease (COPD). PLoS One 10(10):e0122771. doi:10.1371/journal.pone.0122771
Barnes PJ (2004a) Macrophages as orchestrators of COPD. J COPD 1:50–70
Barnes PJ (2004b) Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 56(4):515–548. doi:10.1124/pr.56.4.2
Berenson CS, Garlipp MA, Grove LJ, Maloney J, Sethi S (2006) Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis 194(10):1375–1384. doi:10.1086/508428
Bhavsar P, Hew M, Khorasani N, Torrego A, Barnes PJ, Adcock I, Chung KF (2008) Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma. Thorax 63(9):784–790. doi:10.1136/thx.2007.090027
Bianchi SM, Prince LR, McPhillips K, Allen L, Marriott HM, Taylor GW, Hellewell PG, Sabroe I, Dockrell DH, Henson PW, Whyte MK (2008) Impairment of apoptotic cell engulfment by pyocyanin, a toxic metabolite of Pseudomonas aeruginosa. Am J Respir Crit Care Med 177(1):35–43. doi:10.1164/rccm.200612-1804OC
Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M (1995) Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 152(6 Pt 1):2111–2118. doi:10.1164/ajrccm.152.6.8520783
Bruscia EM, Bonfield TL (2016) Cystic fibrosis lung immunity: the role of the macrophage. J Innate Immun 8(6):550–563. doi:10.1159/000446825
Busse WW, Lemanske RF (2001) Asthma. N Engl J Med 344:350–362
Chana KK, Fenwick PS, Nicholson AG, Barnes PJ, Donnelly LE (2014) Identification of a distinct glucocorticosteroid-insensitive pulmonary macrophage phenotype in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 133(1):207–216 (e201–211). doi:10.1016/j.jaci.2013.08.044
Chmiel JF, Berger M, Konstan MW (2002) The role of inflammation in the pathophysiology of CF lung disease. Clin Rev Allergy Immunol 23(1):5–27. doi:10.1385/CRIAI:23:1:005
Cosio BG, Tsaprouni L, Ito K, Jazrawi E, Adcock IM, Barnes PJ (2004) Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 200(5):689–695. doi:10.1084/jem.20040416
Costa C, Rufino R, Traves SL, Lapa ESJR, Barnes PJ, Donnelly LE (2008) CXCR3 and CCR5 chemokines in induced sputum from patients with COPD. Chest 133(1):26–33. doi:10.1378/chest.07-0393
Croasdell A, Thatcher TH, Kottmann RM, Colas RA, Dalli J, Serhan CN, Sime PJ, Phipps RP (2015) Resolvins attenuate inflammation and promote resolution in cigarette smoke-exposed human macrophages. Am J Physiol Lung Cell Mol Physiol 309(8):L888–L901. doi:10.1152/ajplung.00125.2015
Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, Barnes PJ (2003) Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167(1):24–31. doi:10.1164/rccm.200204-298OC
Del Porto P, Cifani N, Guarnieri S, Di Domenico EG, Mariggio MA, Spadaro F, Guglietta S, Anile M, Venuta F, Quattrucci S, Ascenzioni F (2011) Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa. PLoS One 6(5):e19970. doi:10.1371/journal.pone.0019970
Desch AN, Gibbings SL, Goyal R, Kolde R, Bednarek J, Bruno T, Slansky JE, Jacobelli J, Mason R, Ito Y, Messier E, Randolph GJ, Prabagar M, Atif SM, Segura E, Xavier RJ, Bratton DL, Janssen WJ, Henson PM, Jakubzick CV (2016) Flow cytometric analysis of mononuclear phagocytes in nondiseased human lung and lung-draining lymph nodes. Am J Respir Crit Care Med 193(6):614–626. doi:10.1164/rccm.201507-1376OC
Di A, Brown ME, Deriy LV, Li C, Szeto FL, Chen Y, Huang P, Tong J, Naren AP, Bindokas V, Palfrey HC, Nelson DJ (2006) CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 8(9):933–944. doi:10.1038/ncb1456
Donaldson GC, Seemungal TAR, Bhowmik A, Wedzicha JA (2002) Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57(10):847–852. doi:10.1136/thorax.57.10.847
Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B (2005) Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 8(6):68
Duncan CJ, Lawrie A, Blaylock MG, Douglas JG, Walsh GM (2003) Reduced eosinophil apoptosis in induced sputum correlates with asthma severity. Eur Respir J 22(3):484–490. doi:10.1183/09031936.03.00109803a
Ferrara F, D’Adda D, Falchi M, Dall’Asta L (1996) The macrophagic activity of patients affected by pneumonia or chronic obstructive pulmonary disease. Int J Tissue React 18(4–6):109–114
Finlay GA, O’Driscoll LR, Russell KJ, D’Arcy EM, Masterson JB, FitzGerald MX, O’Connor CM (1997) Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 156(1):240–247
Fitzpatrick AM, Holguin F, Teague WG, Brown LAS (2008) Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J Allergy Clin Immunol 121(6):1372–1378. doi:10.1016/j.jaci.2008.03.008
Frankenberger M, Passlick B, Hofer T, Siebeck M, Maier KL, Ziegler-Heitbrock LH (2000) Immunologic characterization of normal human pleural macrophages. Am J Respir Cell Mol Biol 23(3):419–426
Frankenberger M, Eder C, Hofer TP, Heimbeck I, Skokann K, Kassner G, Weber N, Moller W, Ziegler-Heitbrock L (2011) Chemokine expression by small sputum macrophages in COPD. Mol Med 17(7–8):762–770. doi:10.2119/molmed.2010.00202
George SN, Garcha DS, Mackay AJ, Patel ARC, Singh R, Sapsford RJ, Donaldson GC, Wedzicha JA (2014) Human rhinovirus infection during naturally occurring COPD exacerbations. Eur Respir J 44:87–96
Gern JE, Dick EC, Lee WM, Murray S, Meyer K, Handzel ZT, Busse WW (1996) Rhinovirus enters but does not replicate inside monocytes and airway macrophages. J Immunol 156(2):621–627
Girodet PO, Nguyen D, Mancini JD, Hundal M, Zhou X, Israel E, Cernadas M (2016) Alternative macrophage activation is increased in asthma. Am J Respir Cell Mol Biol 55(4):467–475. doi:10.1165/rcmb.2015-0295OC
Haggie PM, Verkman AS (2007) Cystic fibrosis transmembrane conductance regulator-independent phagosomal acidification in macrophages. J Biol Chem 282(43):31422–31428. doi:10.1074/jbc.M705296200
Han MK, Huang YJ, LiPuma JJ, Boushey HA, Boucher RC, Cookson WO, Curtis JL, Erb-Downward J, Lynch SV, Sethi S, Toews GB, Young VB, Wolfgang MC, Huffnagle GB, Martinez FJ (2012) Significance of the microbiome in obstructive lung disease. Thorax 67(5):456–463. doi:10.1136/thoraxjnl-2011-201183
Harvey CJ, Thimmulappa RK, Sethi S, Kong X, Yarmus L, Brown RH, Feller-Kopman D, Wise R, Biswal S (2011) Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med 3(78):78ra32. doi:10.1126/scitranslmed.3002042
Henson PM, Tuder RM (2008) Apoptosis in the lung: induction, clearance and detection. Am J Physiol Lung Cell Mol Physiol 294(4):L601–L611. doi:10.1152/ajplung.00320.2007
Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA (2000) Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 109(4):288–295
Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M (2003) Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol 81(4):289–296. doi:10.1046/j.1440-1711.2003.t01-1-01170.x
Hodge S, Hodge G, Holmes M, Reynolds PN (2005) Increased airway epithelial and T-cell apoptosis in COPD remains despite smoking cessation. Eur Respir J 25(3):447–454
Hodge S, Hodge G, Ahern J, Jersmann H, Holmes M, Reynolds PN (2007) Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 37(6):748–755. doi:10.1165/rcmb.2007-0025OC
Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M, Reynolds PN (2008) Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008(178):2
Hodge S, Matthews G, Mukaro V, Ahern J, Shivam A, Hodge G, Holmes M, Jersmann H, Reynolds PN (2010) Cigarette smoke-induced changes to alveolar macrophage phenotype and function is improved by treatment with procysteine. Am J Respir Cell Mol Biol 44(5):673–681. doi:10.1165/rcmb.2009-0459OC
Huynh ML, Malcolm KC, Kotaru C, Tilstra JA, Westcott JY, Fadok VA, Wenzel SE (2005) Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages. Am J Respir Crit Care Med 172(8):972–979. doi:10.1164/rccm.200501-035OC
Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ (2005) Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352(19):1967–1976. doi:10.1056/NEJMoa041892
Jeffery PK (1999) Differences and similarities between chronic obstructive pulmonary disease and asthma. Clin Exp Allergy 29(Suppl 2):14–26
Kirkham PA, Spooner G, Rahman I, Rossi AG (2004) Macrophage phagocytosis of apoptotic neutrophils is compromised by matrix proteins modified by cigarette smoke and lipid peroxidation products. Biochem Biophys Res Commun 318(1):32–37. doi:10.1016/j.bbrc.2004.04.003
Kopf M, Schneider C, Nobs SP (2015) The development and function of lung-resident macrophages and dendritic cells. Nat Immunol 16(1):36–44. doi:10.1038/ni.3052
Lay JC, Alexis NE, Zeman KL, Peden DB, Bennett WD (2009) In vivo uptake of inhaled particles by airway phagocytes is enhanced in patients with mild asthma compared with normal volunteers. Thorax 64(4):313–320
Liang Z, Zhang Q, Thomas CM, Chana KK, Gibeon D, Barnes PJ, Chung KF, Bhavsar PK, Donnelly LE (2014) Impaired macrophage phagocytosis of bacteria in severe asthma. Respir Res 15:72
Lofdahl JM, Wahlstrom J, Skold CM (2006) Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers. Clin Exp Immunol 145(3):428–437. doi:10.1111/j.1365-2249.2006.03154.x
Lundborg M, Johard U, Lastbom L, Gerde P, Camner P (2001) Human alveolar macrophage phagocytic function is impaired by aggregates of ultrafine carbon particles. Environ Res 86(3):244–253. doi:10.1006/enrs.2001.4269
Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, Aniscenko J, Laza-Stanca V, Edwards MR, Slater L, Papi A, Stanciu LA, Kon OM, Johnson M, Johnston SL (2011) Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 183(6):734–742. doi:10.1164/rccm.201006-0833OC
Metcalfe HJ, Lea S, Hughes D, Khalaf R, Abbott-Banner K, Singh D (2014) Effects of cigarette smoke on Toll-like receptor (TLR) activation of chronic obstructive pulmonary disease (COPD) macrophages. Clin Exp Immunol 176(3):461–472. doi:10.1111/cei.12289
Morimoto K, Janssen WJ, Terada M (2012) Defective efferocytosis by alveolar macrophages in IPF patients. Respir Med 106(12):1800–1803. doi:10.1016/j.rmed.2012.08.020
Nielsen H, Bonde J (1986) Association of defective monocyte chemotaxis with recurrent acute exacerbations in chronic obstructive lung disease. Eur J Respir Dis 68(3):200–206
Oliver BG, Lim S, Wark P, Laza-Stanca V, King N, Black JL, Burgess JK, Roth M, Johnston SL (2008) Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages. Thorax 63(6):519–525
Pappas K, Papaioannou AI, Kostikas K, Tzanakis N (2013) The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma. Cytokine 64(3):613–625. doi:10.1016/j.cyto.2013.09.010
Park GY, Christman JW (2016) Hidden in plain sight: the overlooked role of pulmonary macrophages in the pathogenesis of asthma. Am J Respir Cell Mol Biol 55(4):465–466. doi:10.1165/rcmb.2016-0188ED
Pons AR, Noguera A, Blanquer D, Sauleda J, Pons J, Agustí AGN (2005) Phenotypic characterisation of alveolar macrophages and peripheral blood monocytes in COPD. Eur Respir J 25:647–652
Ritts RE, Miller RD, LeDuc PV, Offord KP (1976) Phagocytosis and cutaneous delayed hypersensitivity in patients with chronic obstructive pulmonary disease. Chest 69(4):474–478
Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ (2002a) Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 26(5):602–609. doi:10.1165/ajrcmb.26.5.4685
Russell RE, Thorley A, Culpitt SV, Dodd S, Donnelly LE, Demattos C, Fitzgerald M, Barnes PJ (2002b) Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. Am J Physiol Lung Cell Mol Physiol 283(4):L867–L873
Sapey E, Stockley RA (2006) COPD exacerbations: aetiology. Thorax 61(3):250–258
Savici D, Campbell PA, King TE Jr (1989) Bronchoalveolar macrophages from patients with idiopathic pulmonary fibrosis are unable to kill facultative intracellular bacteria. Am Rev Respir Dis 139(1):22–27. doi:10.1164/ajrccm/139.1.22
Shaykhiev R, Krause A, Salit J, Strulovici-Barel Y, Harvey BG, O’Connor TP, Crystal RG (2009) Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 183(4):2867–2883. doi:10.4049/jimmunol.0900473
Simonin-Le Jeune K, Le Jeune A, Jouneau S, Belleguic C, Roux PF, Jaguin M, Dimanche-Boitre MT, Lecureur V, Leclercq C, Desrues B, Brinchault G, Gangneux JP, Martin-Chouly C (2013) Impaired functions of macrophage from cystic fibrosis patients: CD11b, TLR-5 decrease and sCD14, inflammatory cytokines increase. PLoS One 8(9):e75667. doi:10.1371/journal.pone.0075667
Singh AM, Busse WW (2006) Asthma exacerbations. 2: aetiology. Thorax 61(9):809–816. doi:10.1136/thx.2005.045179
Stahl M, Schupp J, Jäger B, Schmid M, Zissel G, Müller-Quernheim J, Prasse A (2013) Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation. PLoS One 8(11):e81382. doi:10.1371/journal.pone.0081382
Staples KJ, Hinks TS, Ward JA, Gunn V, Smith C, Djukanovic R (2012) Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17. J Allergy Clin Immunol 130(6):1404–1412 (e1407). doi:10.1016/j.jaci.2012.07.023
Taylor AE, Finney-Hayward TK, Quint JK, Thomas CM, Tudhope SJ, Wedzicha JA, Barnes PJ, Donnelly LE (2010) Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J 35(5):1039–1047. doi:10.1183/09031936.00036709
Valenza G, Tappe D, Turnwald D, Frosch M, Konig C, Hebestreit H, Abele-Horn M (2008) Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros 7(2):123–127
Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, Brain JD, Accurso FJ, Henson PM (2002) Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 109(5):661–670. doi:10.1172/JCI13572
Vandivier RW, Henson PM, Douglas IS (2006) Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129(6):1673–1682. doi:10.1378/chest.129.6.1673
Vecchiarelli A, Dottorini M, Puliti M, Todisco T, Cenci E, Bistoni F (1991) Defective candidacidal activity of alveolar macrophages and peripheral blood monocytes from patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 143(5 Pt 1):1049–1054. doi:10.1164/ajrccm/143.5_Pt_1.1049
Walsh GM (2008) Defective apoptotic cell clearance in asthma and COPD—a new drug target for statins? Trends Pharmacol Sci 29(1):6–11. doi:10.1016/j.tips.2007.11.002
Wedzicha JA, Donaldson GC (2003) Exacerbations of chronic obstructive pulmonary disease. Respir Care 48(12):1204–1213. Discussion 1213–1205
Wellington M, Bliss JM, Haidaris CG (2003) Enhanced phagocytosis of Candida species mediated by opsonization with recombinant human antibody single chain variable fragment. Infect Immun 71(12):7228–7231
Wilkinson TM, Patel IS, Wilks M, Donaldson GC, Wedzicha JA (2003) Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167(8):1090–1095. doi:10.1164/rccm.200210-1179OC
Wojtan P, Mierzejewski M, Osinska I, Domagala-Kulawik J (2016) Macrophage polarization in interstitial lung diseases. Cent Eur J Immunol 41(2):159–164. doi:10.5114/ceji.2016.60990
Wright AK, Rao S, Range S, Eder C, Hofer TP, Frankenberger M, Kobzik L, Brightling C, Grigg J, Ziegler-Heitbrock L (2009) Pivotal advance: expansion of small sputum macrophages in CF: failure to express MARCO and mannose receptors. J Leukoc Biol 86(3):479–489. doi:10.1189/jlb.1108699
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Belchamber, K.B.R., Donnelly, L.E. (2017). Macrophage Dysfunction in Respiratory Disease. In: Kloc, M. (eds) Macrophages. Results and Problems in Cell Differentiation, vol 62. Springer, Cham. https://doi.org/10.1007/978-3-319-54090-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-54090-0_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54089-4
Online ISBN: 978-3-319-54090-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)